Review




Structured Review

Empatica Inc wrist galvanic skin response empatica e4
Digital biomarkers of non-motor symptoms currently available or under development
Wrist Galvanic Skin Response Empatica E4, supplied by Empatica Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wrist+galvanic+skin+response+empatica+e4/wrist+galvanic+skin+response+empatica+e4/pmc11239921-13-5-9
Average 90 stars, based on 1 article reviews
wrist galvanic skin response empatica e4 - by Bioz Stars, 2026-10
90/100 stars

Images

1) Product Images from "Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art"

Article Title: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art

Journal: NPJ Digital Medicine

doi: 10.1038/s41746-024-01144-2

Digital biomarkers of non-motor symptoms currently available or under development
Figure Legend Snippet: Digital biomarkers of non-motor symptoms currently available or under development

Techniques Used: Control, Biomarker Discovery, Activity Assay, Marker, Software, Standard Deviation, Spectroscopy, Transmission Assay, Comparison, Sampling, Capsules, Muscles, Modification, Battery

Related Articles

Biomarker Discovery:

Article Title: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art
Article Snippet: .. Pain , Skin impedance , Wrist galvanic skin response (Empatica E4) , Early validation, N = 20 postoperative patients. NRS (1–5) for pain score after induced personalized low-intensity painful triggers (walking, coughing). 30-min device measurements. , Accuracy to detect pain decreases with increasing pain score (0 to 1 = 86%; 1 to 2 70%, 2 to 3 = 61.5%, etc.). , Tested in controlled conditions. Higher pain levels associate with higher motion artifacts. , Easy to use watch. Unclear whether pathological skin impedance affects the performance of this method. , N/A , . .. , Facial micro-expressions and voice, movement, behavior, activity and body signals , Mobile application (ePat®) , Early validation, N = 40 with dementia. Application measures compared against Abbey Pain Scale (rated by caregiver) during various moments at rest or post-movement. , High concurrent validity with Abbey Pain Scale if combined with questionnaires in mobile applications ( r = 0.88). Early signs of appropriate discriminant validity (no statistics). , Inter-rater reliability of 0.74 (Cohen’s κ). , Potential difficulty to extrapolate to PD due to hypomimia. Potentially difficult software to operate. Not passive collection of images (yet). , N/A , .



Similar Products

90
Empatica Inc wrist galvanic skin response empatica e4
Digital biomarkers of non-motor symptoms currently available or under development
Wrist Galvanic Skin Response Empatica E4, supplied by Empatica Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wrist+galvanic+skin+response+empatica+e4/wrist+galvanic+skin+response+empatica+e4/pmc11239921-13-5-9
Average 90 stars, based on 1 article reviews
wrist galvanic skin response empatica e4 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Digital biomarkers of non-motor symptoms currently available or under development

Journal: NPJ Digital Medicine

Article Title: Digital biomarkers for non-motor symptoms in Parkinson’s disease: the state of the art

doi: 10.1038/s41746-024-01144-2

Figure Lengend Snippet: Digital biomarkers of non-motor symptoms currently available or under development

Article Snippet: Pain , Skin impedance , Wrist galvanic skin response (Empatica E4) , Early validation, N = 20 postoperative patients. NRS (1–5) for pain score after induced personalized low-intensity painful triggers (walking, coughing). 30-min device measurements. , Accuracy to detect pain decreases with increasing pain score (0 to 1 = 86%; 1 to 2 70%, 2 to 3 = 61.5%, etc.). , Tested in controlled conditions. Higher pain levels associate with higher motion artifacts. , Easy to use watch. Unclear whether pathological skin impedance affects the performance of this method. , N/A , .

Techniques: Control, Biomarker Discovery, Activity Assay, Marker, Software, Standard Deviation, Spectroscopy, Transmission Assay, Comparison, Sampling, Capsules, Muscles, Modification, Battery